Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis

Rheumatology International

Volumn 20, Issue 3, 2001, Pages 113-118

  Komócsi, András ^a   Kumánovics, Gábor ^a   Zibotics, Hilda ^b   Czirják, László ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Baranya County Hospital   (Hungary)

Author keywords

Alveolitis; Bronchoalveolar lavage; Dermato polymyositis; Lung fibrosis; Sclerodermamyositis overlap syndrome

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG ALVEOLITIS; LUNG FIBROSIS; LUNG LAVAGE; LYMPHOCYTE COUNT; POLYMYOSITIS; PRIORITY JOURNAL; SCLERODERMA; SYNDROME;

ADULT; AGED; AZATHIOPRINE; BRONCHOALVEOLAR LAVAGE FLUID; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; METHYLPREDNISOLONE; MIDDLE AGED; NEUTROPHILS; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC;

EID: 0035094912     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960000092     Document Type: Article

References (34)

1. Long-term prognosis of 69 patients with dermatomyositis or polymyositis
2. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis
3. Pulmonary involvement in polymyositis and in dermatomyositis
4. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis
5. Asymptomatic polymyositis with pulmonary disease
6. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function
7. Interstitial pulmonary involvement of polymyositis and dermatomyositis. Apropos of 3 cases. Review of the literature
8. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement
9. Pulmonary involvement in polymyositis and dermatomyositis: Sequential evaluation with CT
10. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis
11. Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases
12. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study
13. Clinical features of polymyositis/dermatomyositis with steroidresistant interstitial lung disease
14. Clinical and subclinical alveolitis in connective tissue diseases assessed by bronchoalveolar lavage
15. Polymyositis and dermatomyositis (first of two parts)
16. Standardized function testing. Report of working party on standardized lung function tests
17. High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma
18. Investigation of the alveolar macrophages and T lymphocytes in 15 patients with systemic-sclerosis
19. Course of interstitial lung diseases associated with inflammatory myopathies. Apropos of 5 cases
20. Cyclosporine treatment for polymyositis/dermatomyositis: Is it possible to rescue the deteriorating cases with interstitial pneumonitis?
21. Interstitial lung disease in polymyositis and dermatomyositis
22. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes
23. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-I antibodies
24. Anti-Jo-1 antibodies: Specific autoantibodies for polymyositis with interstitial pulmonary fibrosis. Two case reports
25. Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis
26. Two cases of acute progressive interstitial pneumonia associated with dermatomyositis - Clinical features and immunological disorders
27. Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis
28. Malignancy associated dermatomyositis with fibrosing alveolitis. Report of a case with a discussion of the management
29. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis
30. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups
31. The precipitating antibody to an acidic nuclear protein antigen, the Jo-l, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis
32. Interstitial lung disease as the presentation of anti-Jo-1 positive polymyositis
33. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis
34. Distinctive features of idiopathic inflammatory myopathies in French Canadians